Keyphrases
Hyperglucagonemia
100%
Diabetic Patients
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Incretin Effect
100%
Non-diabetic
100%
Type 2 Diabetic Patients
62%
Liver Disease
37%
Intravenous Glucose
25%
Glucose Infusion
25%
Oral Glucose Tolerance Test
25%
Normal Glucose Tolerance
12%
B Cells
12%
Glucagon-like
12%
Glucose-dependent Insulinotropic Polypeptide
12%
Glucagon
12%
Intolerance
12%
Result Control
12%
Without Diabetes
12%
Kruskal-Wallis Test
12%
Body Mass Index
12%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Hyperglucagonemia
100%
Incretin
100%
Patient with Type 2 Diabetes
62%
Liver Disease
37%
Glucose Infusion
25%
Oral Glucose Tolerance Test
25%
Glucagon
12%
Glucagon Like Peptide 1
12%
Body Mass Index
12%
Kruskal Wallis Test
12%
Gastric Inhibitory Polypeptide
12%
Glucose Tolerance
12%
Diabetes
12%
Beta Cell
12%